Insider-Detail
KURAKura Oncology, Inc.
$1.0B MCKurs $11.7316% unter 52w-HighØ Volumen $31.3M/Tag
51Composite Score (0–100): gewichtete Gesamtbewertung eines Insider-Kaufs aus Cluster, Rolle, Größe, Position-Uplift u. a. Ab 70 = Buy-Alert, ab 85 = Strong Buy.
WATCH
Trade Republic ↗Insider-Volumen (Käufe vs. Verkäufe)Transaktionsdatum vs. Meldedatum: Insider-Trades werden erst Tage später öffentlich (SEC ~T+2, EU bis ~T+5). Das Transaktionsdatum zählt für die Bewertung.
Käufe $1.2M Verkäufe $2.9M
Max $1.2MFaktor-Breakdown
Cluster (≥2 Insider in 7d)0 / 25
Rolle (CEO/CFO/...)20 / 20
Trade-Größe (USD)9 / 15
Position-Uplift (%)8 / 10
Opportunistic vs Routine0 / 10
Market Cap (Small/Mid)8 / 8
Bewertung (FCF/PE)0 / 5
Timing (Drawdown)0 / 4
Short Interest0 / 3
Bonus-Signale (cap +15)
Spike (großer Standout-Kauf)4 / 5
Congress-Trade-Confluence0 / 5
Handelsvolumen / Liquidität2 / 3
Reddit Sentiment0 / 3
ETF / Sektor-Trend0 / 2
Sentiment (Reddit · Wikipedia · News)
Noch keine Analyse für KURA. Klick auf den Button oben.
| Datum | Insider | Position | Typ | Shares | Bestand danach | Volumen | Trade %Trade %: Anteil der zuvor gehaltenen Aktien, den der Insider mit diesem Trade dazugekauft (Buy) bzw. verkauft (Sell) hat. "neu" = komplett neue Position. Aussagekräftiger als die absolute Größe — ein CEO, der seine Position um 50 % aufstockt, signalisiert mehr Überzeugung als ein absolut großer, aber relativ winziger Kauf. |
|---|---|---|---|---|---|---|---|
| 24. Aug. 2026 | WILSON TROY EDWARD | President and CEO | BUY | 100.0k | 479.2k | $1.2M | +26% |
| 21. Aug. 2026 | Powl Brian T. | Chief Commercial Officer | SELL | 4.3k | 169.3k | $52k | −2.5% |
| 18. Juni 2026 | Leoni Mollie | Chief Medical Officer | SELL | 84.9k | 182.3k | $834k | −32% |
| 21. Mai 2026 | Powl Brian T. | Chief Commercial Officer | SELL | 10.0k | 173.6k | $110k | −5.4% |
| 19. Mai 2026 | Powl Brian T. | Chief Commercial Officer | SELL | 339 | 183.6k | $3k | −0.2% |
| 19. Mai 2026 | FORD KATHLEEN | Chief Operating Officer | SELL | 2.3k | 153.6k | $20k | −1.4% |
| 18. Mai 2026 | Bair Teresa Brophy | Chief Legal Officer | SELL | 2.3k | 226.9k | $21k | −1.0% |
| 27. Jan. 2026 | Leoni Mollie | Chief Medical Officer | SELL | 951 | 268.6k | $8k | −0.4% |
| 27. Jan. 2026 | Powl Brian T. | Chief Commercial Officer | SELL | 4.8k | 184.8k | $41k | −2.6% |
| 27. Jan. 2026 | Powl Brian T. | Chief Commercial Officer | SELL | 1.6k | 183.3k | $13k | −0.9% |
| 27. Jan. 2026 | FORD KATHLEEN | Chief Operating Officer | SELL | 1.8k | 153.6k | $15k | −1.2% |
| 27. Jan. 2026 | Leoni Mollie | Chief Medical Officer | SELL | 3.7k | 271.8k | $31k | −1.3% |
| 27. Jan. 2026 | Leoni Mollie | Chief Medical Officer | SELL | 2.2k | 269.6k | $19k | −0.8% |
| 27. Jan. 2026 | Leoni Mollie | Chief Medical Officer | SELL | 1.3k | 267.3k | $11k | −0.5% |
| 27. Jan. 2026 | DOYLE THOMAS JAMES | SVP, Finance & Accounting | SELL | 2.2k | 150.1k | $19k | −1.5% |
| 27. Jan. 2026 | DOYLE THOMAS JAMES | SVP, Finance & Accounting | SELL | 1.1k | 149.0k | $9k | −0.7% |
| 27. Jan. 2026 | DOYLE THOMAS JAMES | SVP, Finance & Accounting | SELL | 695 | 148.3k | $6k | −0.5% |
| 27. Jan. 2026 | DOYLE THOMAS JAMES | SVP, Finance & Accounting | SELL | 881 | 145.2k | $7k | −0.6% |
| 27. Jan. 2026 | Burrows Francis | Chief Scientific Officer | SELL | 1.3k | 32.4k | $11k | −3.9% |
| 27. Jan. 2026 | Bair Teresa Brophy | Chief Legal Officer | SELL | 4.1k | 234.0k | $35k | −1.7% |
| 27. Jan. 2026 | Bair Teresa Brophy | Chief Legal Officer | SELL | 2.3k | 231.7k | $20k | −1.0% |
| 27. Jan. 2026 | Bair Teresa Brophy | Chief Legal Officer | SELL | 4.8k | 226.9k | $40k | −2.1% |
| 18. Dez. 2025 | Burrows Francis | Chief Scientific Officer | SELL | 23.7k | 33.7k | $232k | −41% |
| 09. Dez. 2025 | Hasnain Faheem | DIRECTOR | SELL | 10.0k | 24.0k | $110k | −29% |
| 14. Nov. 2025 | Bair Teresa Brophy | Chief Legal Officer | SELL | 8.8k | 188.1k | $98k | −4.5% |
| 14. Nov. 2025 | Powl Brian T. | Chief Commercial Officer | SELL | 8.9k | 139.7k | $99k | −6.0% |
| 14. Nov. 2025 | Leoni Mollie | Chief Medical Officer | SELL | 15.5k | 225.5k | $173k | −6.4% |
| 14. Nov. 2025 | DOYLE THOMAS JAMES | SVP, Finance & Accounting | SELL | 4.5k | 130.3k | $51k | −3.4% |
| 14. Nov. 2025 | FORD KATHLEEN | Chief Operating Officer | SELL | 6.9k | 105.4k | $77k | −6.1% |
| 29. Sept. 2025 | Powl Brian T. | Chief Commercial Officer | SELL | 8.9k | 99.7k | $80k | −8.2% |
| 29. Sept. 2025 | Bair Teresa Brophy | Chief Legal Officer | SELL | 8.8k | 148.0k | $79k | −5.6% |
| 29. Sept. 2025 | FORD KATHLEEN | Chief Operating Officer | SELL | 6.9k | 63.4k | $62k | −9.8% |
| 29. Sept. 2025 | Leoni Mollie | Chief Medical Officer | SELL | 12.3k | 158.4k | $110k | −7.2% |
| 29. Sept. 2025 | WILSON TROY EDWARD | President and CEO | SELL | 36.6k | 246.9k | $327k | −13% |
| 29. Sept. 2025 | DOYLE THOMAS JAMES | SVP, Finance & Accounting | SELL | 4.5k | 109.8k | $41k | −4.0% |